Christian Loch

Christian Loch joined RBC in 2023 as Director of Kinase Assay Services and manages the team responsible for the company’s signature Hotspot drug-screening assay. Previously, he served as Co-founder, Chief Executive and Science Officer of AVMBioMed, a CRO specialized in proteomic assays informative to post-translational modification and protein expression. Prior to that, he served as Assistant Director of Research & Development at LifeSensors, a biotechnology company focused on the ubiquitin pathway. Dr. Loch has over 15 years industry experience and has successfully commercialized various reagents and assays. He received his PhD from the University of Virginia studying epigenetics, a Master’s in Public Health Epidemiology from the University of Washington and was an American Cancer Society Postdoctoral Fellow at the Fred Hutchinson Cancer Research Center in Seattle. In addition to his professional work, Christian has maintained involvement with the academic community, serving as Adjunct Professor at Villanova University, Executive Advisory Council Member at James Madison University, and Visiting Lecturer at West Chester University.